{"transactions":[{"id":725412,"issuer":{"id":7135,"kind":"organization","name":"MYOMO, INC.","symbol":"MYO"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:10:10.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":78704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026."}],"balance_after":123704,"source":{"system":"sec-edgar","filing":"0001193125-26-285686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000119312526285686/ownership.xml","form_type":"4"}},{"id":806937,"issuer":{"id":7135,"kind":"organization","name":"MYOMO, INC.","symbol":"MYO"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:28:12.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (\"RSU's\") under the Issuer's 2018 Stock Option and Incentive Plan.  The RSU's vest in their entirety on the first anniversary of the grant date."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001193125-26-159101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000119312526159101/ownership.xml","form_type":"4"}},{"id":1255620,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-20T18:40:27.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":6.64,"value":2662.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":600852,"source":{"system":"sec-edgar","filing":"0001628280-25-006692","document":"wk-form4_1740076821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025006692/wk-form4_1740076821.xml","form_type":"4"}},{"id":1330743,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-16T19:28:39.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5.011,"value":100220.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.01 to $5.05. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":601253,"source":{"system":"sec-edgar","filing":"0001628280-24-051352","document":"wk-form4_1734377313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024051352/wk-form4_1734377313.xml","form_type":"4"}},{"id":1390718,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-04T17:17:00.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each stock option (the \"Company Option\") that was outstanding, unexercised and vested as of immediately prior to the Effective Time with a per share exercise price (\"Per Share Exercise Price\") that was less than the Merger Consideration, was cancelled and converted into the right to receive an amount in cash (without interest and less any applicable withholding taxes) equal to the product of (i) the aggregate number of shares of common stock of Augmedix (the \"Company Common Stock\") underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the Per Share Exercise Price of such Company Option. Each Company Option that had a Per Share Exercise Price that was equal to or exceeded the amount of the Merger Consideration at the Effective Time was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Company Option that was unvested and had a Per Share Exercise Price that was less than the amount of the Merger Consideration at the Effective Time was replaced with a cash incentive program, which in either case preserves the compensation elements and vesting terms of the Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is granted under the Augmedix 2020 Equity Incentive Plan. The option will vest monthly in equal increments for one (1) year starting on March 28, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date, and will be fully vested on March 28, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.8,"expiration_date":"2032-03-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-085379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390024085379/ownership.xml","form_type":"4"}},{"id":1390717,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-04T17:17:00.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":162583,"price":2.35,"value":382070.05,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Disposed of in connection with the merger of Augmedix, Inc. (\"Augmedix\") with and into Anderson Merger Sub, Inc. (the \"Merger Sub\"), effective October 2, 2024 (the \"Merger\"), pursuant to the Agreement and Plan of Merger dated as of July 19, 2024, among Augmedix, Commure, Inc., and Merger Sub (the \"Merger Agreement\"). In connection with the Merger, the shares listed were canceled and converted into the right to receive $2.35 per share, without interest (the \"Merger Consideration\"), and subject to applicable tax withholdings."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-24-085379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390024085379/ownership.xml","form_type":"4"}},{"id":1454498,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-07-16T01:58:48.000Z","date":"2024-07-13","kind":"exercise","planned":false,"acquired":false,"shares":21598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 13, 2023 (the \"Grant Date\"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 13, 2023 (the \"Grant Date\"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21598},"source":{"system":"sec-edgar","filing":"0001213900-24-061515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390024061515/ownership.xml","form_type":"4"}},{"id":1454497,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T01:58:48.000Z","date":"2024-07-13","kind":"exercise","planned":false,"acquired":true,"shares":21598,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":162583,"source":{"system":"sec-edgar","filing":"0001213900-24-061515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390024061515/ownership.xml","form_type":"4"}},{"id":1481980,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-06-12T15:41:35.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":false,"shares":28895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":57790,"derivative":{"underlying":"Common","underlying_shares":28895},"source":{"system":"sec-edgar","filing":"0001628280-24-027755","document":"wk-form4_1718206887.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027755/wk-form4_1718206887.xml","form_type":"4"}},{"id":1481979,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-06-12T15:41:35.000Z","date":"2024-04-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":782,"price":9.35,"value":7311.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":581253,"source":{"system":"sec-edgar","filing":"0001628280-24-027755","document":"wk-form4_1718206887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027755/wk-form4_1718206887.xml","form_type":"4"}},{"id":1481978,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-06-12T15:41:35.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":true,"shares":28895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's prior holdings were previously inadvertently overstated by four shares."}],"balance_after":582035,"source":{"system":"sec-edgar","filing":"0001628280-24-027755","document":"wk-form4_1718206887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027755/wk-form4_1718206887.xml","form_type":"4"}},{"id":1536109,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-24T14:20:10.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant."}],"balance_after":553144,"source":{"system":"sec-edgar","filing":"0001628280-24-017552","document":"wk-form4_1713968401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024017552/wk-form4_1713968401.xml","form_type":"4"}},{"id":1539883,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-17T21:22:51.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on April 15, 2025, which is the first anniversary of the date of grant."}],"balance_after":538144,"source":{"system":"sec-edgar","filing":"0001628280-24-016621","document":"wk-form4_1713388959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024016621/wk-form4_1713388959.xml","form_type":"4"}},{"id":1676287,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-18T22:56:07.000Z","date":"2024-01-09","kind":"exercise","planned":false,"acquired":false,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9628},"source":{"system":"sec-edgar","filing":"0001628280-24-001718","document":"wk-form4_1705618557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024001718/wk-form4_1705618557.xml","form_type":"4"}},{"id":1676286,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-18T22:56:07.000Z","date":"2024-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2884,"price":13.25,"value":38213.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":478144,"source":{"system":"sec-edgar","filing":"0001628280-24-001718","document":"wk-form4_1705618557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024001718/wk-form4_1705618557.xml","form_type":"4"}},{"id":1676285,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-18T22:56:07.000Z","date":"2024-01-09","kind":"exercise","planned":false,"acquired":true,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":481028,"source":{"system":"sec-edgar","filing":"0001628280-24-001718","document":"wk-form4_1705618557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024001718/wk-form4_1705618557.xml","form_type":"4"}},{"id":1828567,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-17T21:36:54.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":21598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Unit (\"RSU\") is granted under the Augmedix, Inc. (the \"Issuer\") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date."}],"balance_after":21598,"derivative":{"exercise_price":4.63,"underlying":"Common Stock","underlying_shares":21598},"source":{"system":"sec-edgar","filing":"0001213900-23-057479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390023057479/ownership.xml","form_type":"4"}},{"id":1837428,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:30:21.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":91605,"source":{"system":"sec-edgar","filing":"0001213900-23-054872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390023054872/ownership.xml","form_type":"4"}},{"id":1846976,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-22T21:05:00.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the second anniversary of the date of grant."}],"balance_after":37500,"derivative":{"exercise_price":3.37,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001362118-23-000046","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000046/primary_doc.xml","form_type":"4"}},{"id":1846975,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Common Stock","published_at":"2023-06-22T21:05:00.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant of restricted stock shares vests 37,500 shares immediately and the remaining 37,500 shares on the second anniversary of the date of grant."}],"balance_after":450000,"source":{"system":"sec-edgar","filing":"0001362118-23-000046","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000136211823000046/primary_doc.xml","form_type":"4"}},{"id":1851927,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-16T21:50:31.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 16, 2022 (the \"Grant Date\"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 16, 2022 (the \"Grant Date\"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001213900-23-049755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390023049755/ownership.xml","form_type":"4"}},{"id":1851926,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T21:50:31.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":52632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":140985,"source":{"system":"sec-edgar","filing":"0001213900-23-049755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390023049755/ownership.xml","form_type":"4"}},{"id":1916422,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2023-04-20T19:15:46.000Z","date":"2023-04-18","kind":"grant","planned":false,"acquired":true,"shares":161698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date."}],"balance_after":161698,"derivative":{"exercise_price":14.42,"expiration_date":"2028-04-17","underlying":"Common","underlying_shares":161698},"source":{"system":"sec-edgar","filing":"0001628280-23-012245","document":"wf-form4_168201813371638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023012245/wf-form4_168201813371638.xml","form_type":"4"}},{"id":1916421,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-04-20T19:15:46.000Z","date":"2023-04-18","kind":"grant","planned":false,"acquired":true,"shares":86685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date."}],"balance_after":86685,"derivative":{"underlying":"Common","underlying_shares":86685},"source":{"system":"sec-edgar","filing":"0001628280-23-012245","document":"wf-form4_168201813371638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023012245/wf-form4_168201813371638.xml","form_type":"4"}},{"id":1932926,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T21:48:47.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":89105,"source":{"system":"sec-edgar","filing":"0001213900-23-026436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390023026436/ownership.xml","form_type":"4"}},{"id":2040230,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-01-31T21:50:44.000Z","date":"2023-01-07","kind":"exercise","acquired":false,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":9628,"derivative":{"underlying":"Common Stock","underlying_shares":9628},"source":{"system":"sec-edgar","filing":"0001628280-23-001817","document":"wf-form4_167520183165358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023001817/wf-form4_167520183165358.xml","form_type":"4"}},{"id":2040229,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-31T21:50:44.000Z","date":"2023-01-07","kind":"exercise","acquired":true,"shares":9628,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":471400,"source":{"system":"sec-edgar","filing":"0001628280-23-001817","document":"wf-form4_167520183165358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023001817/wf-form4_167520183165358.xml","form_type":"4"}},{"id":2073172,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T21:31:15.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":86605,"source":{"system":"sec-edgar","filing":"0001019056-23-000002","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905623000002/febbo.xml","form_type":"4"}},{"id":2147841,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-03T18:48:43.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":84105,"source":{"system":"sec-edgar","filing":"0001019056-22-000607","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000607/febbo.xml","form_type":"4"}},{"id":2176061,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-23T20:45:17.000Z","date":"2022-08-22","kind":"purchase","acquired":true,"shares":10700,"price":15.2936,"value":163641.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $15.43. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":461772,"source":{"system":"sec-edgar","filing":"0001213900-22-050555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022050555/ownership.xml","form_type":"4"}},{"id":2176060,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-23T20:45:17.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":5400,"price":16.1785,"value":87363.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.13 to $16.24. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":451072,"source":{"system":"sec-edgar","filing":"0001213900-22-050555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022050555/ownership.xml","form_type":"4"}},{"id":2192178,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-08T20:14:13.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":81605,"source":{"system":"sec-edgar","filing":"0001019056-22-000538","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000538/febbo.xml","form_type":"4"}},{"id":2225276,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-21T23:58:44.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Unit (\"RSU\") is granted under the Augmedix, Inc. (the \"Issuer\") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU will vest in full on the one-year anniversary of June 16, 2022, so long as the Reporting Person remains a director on such date."}],"balance_after":52632,"derivative":{"exercise_price":1.9,"underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001213900-22-034065","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390022034065/ownership.xml","form_type":"4"}},{"id":2253210,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T00:46:09.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":30000,"price":1.99,"value":59700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades ranging from $1.98 to $2.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":88353,"source":{"system":"sec-edgar","filing":"0001213900-22-030199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000121390022030199/ownership.xml","form_type":"4"}},{"id":2309207,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:00:41.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":5981,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":79105,"source":{"system":"sec-edgar","filing":"0001019056-22-000310","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000310/febbo.xml","form_type":"4"}},{"id":2314121,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-30T20:52:47.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is granted under the Augmedix, Inc. (the \"Issuer\") 2020 Equity Incentive Plan. The option will vest monthly in equal increments for one (1) year starting on March 28, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date, and will be fully vested on March 28, 2023."}],"balance_after":50000,"derivative":{"exercise_price":2.8,"expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001062993-22-009014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413987/000106299322009014/form4.xml","form_type":"4"}},{"id":2348638,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-07T13:17:36.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":20000,"price":4.02,"value":80400.0,"ownership":{"direct":true},"balance_after":73124,"source":{"system":"sec-edgar","filing":"0001019056-22-000256","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000256/febbo.xml","form_type":"4"}},{"id":2378343,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-02-23T21:45:32.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":400,"price":44.96,"value":17984.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.93 to $44.97. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":445672,"source":{"system":"sec-edgar","filing":"0001213900-22-008987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022008987/ownership.xml","form_type":"4"}},{"id":2378342,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-02-23T21:45:32.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":7066,"price":44.122,"value":311766.052,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.84 to $44.83. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":446072,"source":{"system":"sec-edgar","filing":"0001213900-22-008987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022008987/ownership.xml","form_type":"4"}},{"id":2378341,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-02-23T21:45:32.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":9200,"price":43.379,"value":399086.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.84 to $43.83. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":453138,"source":{"system":"sec-edgar","filing":"0001213900-22-008987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022008987/ownership.xml","form_type":"4"}},{"id":2382935,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock purchase warrant","published_at":"2022-02-22T16:26:37.000Z","date":"2022-02-06","kind":"purchase","acquired":true,"shares":23229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The common stock purchase warrant (the \"Warrant\") was issued to Mr. Febbo on May 11, 2021 (the \"Issuance Date\"). Pursuant to its terms, the Warrant became exercisable on February 6, 2022, the day that is 271 calendar days following the Issuance Date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock purchase warrant (the \"Warrant\") was issued to Mr. Febbo on May 11, 2021 (the \"Issuance Date\"). Pursuant to its terms, the Warrant became exercisable on February 6, 2022, the day that is 271 calendar days following the Issuance Date."}],"balance_after":23229,"derivative":{"exercise_price":6,"exercise_date":"2022-02-06","expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":23229},"source":{"system":"sec-edgar","filing":"0001019056-22-000226","document":"febbo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000226/febbo.xml","form_type":"4"}},{"id":2382934,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock purchase warrant","published_at":"2022-02-22T16:26:37.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":45586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."}],"balance_after":45586,"derivative":{"exercise_price":6.6,"exercise_date":"2022-02-14","expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":45586},"source":{"system":"sec-edgar","filing":"0001019056-22-000226","document":"febbo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000226/febbo.xml","form_type":"4"}},{"id":2382933,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2022-02-22T16:26:37.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":45586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6,"underlying":"Common Stock","underlying_shares":45586},"source":{"system":"sec-edgar","filing":"0001019056-22-000226","document":"febbo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000226/febbo.xml","form_type":"4"}},{"id":2382932,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-22T16:26:37.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":45586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The convertible promissory note (the \"Note\") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer."}],"balance_after":53124,"source":{"system":"sec-edgar","filing":"0001019056-22-000226","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000226/febbo.xml","form_type":"4"}},{"id":2430312,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-20T21:45:20.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":300,"price":48.523,"value":14556.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.385 to $48.80. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":462338,"source":{"system":"sec-edgar","filing":"0001213900-22-002854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022002854/ownership.xml","form_type":"4"}},{"id":2430311,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-20T21:45:20.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":8226,"price":47.572,"value":391327.272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.29 to $48.18. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":462638,"source":{"system":"sec-edgar","filing":"0001213900-22-002854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022002854/ownership.xml","form_type":"4"}},{"id":2430310,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-20T21:45:20.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":8140,"price":46.915,"value":381888.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan, adopted on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $47.28. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":470864,"source":{"system":"sec-edgar","filing":"0001213900-22-002854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022002854/ownership.xml","form_type":"4"}},{"id":2437648,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2022-01-11T21:45:10.000Z","date":"2022-01-07","kind":"tax_withholding","acquired":false,"shares":9627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."}],"balance_after":19256,"derivative":{"expiration_date":"2024-01-07","underlying":"Common Stock","underlying_shares":28883},"source":{"system":"sec-edgar","filing":"0001213900-22-001562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022001562/ownership.xml","form_type":"4"}},{"id":2437647,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-11T21:45:10.000Z","date":"2022-01-07","kind":"tax_withholding","acquired":true,"shares":9627,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."}],"balance_after":479004,"source":{"system":"sec-edgar","filing":"0001213900-22-001562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022001562/ownership.xml","form_type":"4"}},{"id":2454892,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T20:14:12.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":3329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":7538,"source":{"system":"sec-edgar","filing":"0001019056-22-000016","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000016/febbo.xml","form_type":"4"}},{"id":2465891,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-12-17T21:45:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":16666,"price":54.55,"value":909130.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":469377,"source":{"system":"sec-edgar","filing":"0001213900-21-066031","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021066031/ownership.xml","form_type":"4"}},{"id":2507041,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-11-17T21:45:40.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":16666,"price":82.18,"value":1369611.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":486043,"source":{"system":"sec-edgar","filing":"0001213900-21-060341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021060341/ownership.xml","form_type":"4"}},{"id":2539190,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Performance Stock Units","published_at":"2021-10-19T20:45:15.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":182398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The first 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $98.87 or higher for 30 consecutive trading days during the five-year performance period. Another 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $131.82 or higher for 30 consecutive trading days during the five-year performance period. A final 34% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $164.78 or higher for 30 consecutive trading days during the five-year performance period. If earned, the performance stock units will, subject to certain exceptions, vest ratably on the first anniversary of such performance achievement. Any performance stock unit that has not been earned and vested as of the fifth anniversary of the grant date will be forfeited. Vesting of the performance stock units shall accelerate upon a qualifying termination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The first 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $98.87 or higher for 30 consecutive trading days during the five-year performance period. Another 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $131.82 or higher for 30 consecutive trading days during the five-year performance period. A final 34% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $164.78 or higher for 30 consecutive trading days during the five-year performance period. If earned, the performance stock units will, subject to certain exceptions, vest ratably on the first anniversary of such performance achievement. Any performance stock unit that has not been earned and vested as of the fifth anniversary of the grant date will be forfeited. Vesting of the performance stock units shall accelerate upon a qualifying termination."}],"balance_after":182398,"derivative":{"expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":182398},"source":{"system":"sec-edgar","filing":"0001213900-21-053524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021053524/ownership.xml","form_type":"4"}},{"id":2539189,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-10-19T20:45:15.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":16666,"price":84.2,"value":1403277.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":502709,"source":{"system":"sec-edgar","filing":"0001213900-21-053524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021053524/ownership.xml","form_type":"4"}},{"id":2552783,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T17:28:30.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":8389,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":12626,"source":{"system":"sec-edgar","filing":"0001019056-21-000519","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000519/febbo.xml","form_type":"4"}},{"id":2565630,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-09-17T20:45:11.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":16666,"price":65.74,"value":1095622.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":519375,"source":{"system":"sec-edgar","filing":"0001213900-21-048613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021048613/ownership.xml","form_type":"4"}},{"id":2569259,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-09-15T20:45:35.000Z","date":"2021-09-13","kind":"gift","acquired":false,"shares":8600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares represent a charitable gift/donation to the National Philanthropic Trust/William and Vanessa Febbo. The Reporting Person is not a Trustee and has no pecuniary interest or investment discretion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":536041,"source":{"system":"sec-edgar","filing":"0001213900-21-048251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021048251/ownership.xml","form_type":"4"}},{"id":2599959,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-08-17T20:46:07.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":16666,"price":60.46,"value":1007626.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":544641,"source":{"system":"sec-edgar","filing":"0001213900-21-043480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021043480/ownership.xml","form_type":"4"}},{"id":2645712,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T19:39:31.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4237,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."}],"balance_after":4237,"source":{"system":"sec-edgar","filing":"0001019056-21-000405","document":"febbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000405/febbo.xml","form_type":"4"}},{"id":2770513,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option","published_at":"2021-03-26T20:45:19.000Z","date":"2021-03-25","kind":"exercise","acquired":false,"shares":394739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in the above Table 1 Rows 3 and 4 reflect the cashless exercise of a soon to expire stock option. The cashless exercise of the option is reported in two lines. The first line of the cashless exercise transaction is coded M in Column 3 of Table 1 and reports in Column 4 the number of shares issuable upon exercise of the option had cash been paid to exercise the option, together with the exercise price with code A for acquired. The line coded F in Column 3 of Table I relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such options with code D for disposal. The price in Column D reflects the closing price on the date of the cashless exercise. The number of shares on a net basis is actually owned by the Reporting Person after the cashless exercise. The transactions reported in Table II above reflect the disposition of the same stock option whose cashless exercise is disclosed in Table I above. The sales reflected in Table 1, Rows 1 and 2, were sales to generate funds to pay the taxes associated with the cashless exercise."}],"balance_after":0,"derivative":{"exercise_price":3.21,"exercise_date":"2019-02-22","expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":394739},"source":{"system":"sec-edgar","filing":"0001213900-21-018006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021018006/ownership.xml","form_type":"4"}},{"id":2770512,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-03-26T20:45:19.000Z","date":"2021-03-25","kind":"tax_withholding","acquired":false,"shares":26710,"price":47.44,"value":1267122.4,"ownership":{"direct":true},"balance_after":561307,"source":{"system":"sec-edgar","filing":"0001213900-21-018006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021018006/ownership.xml","form_type":"4"}},{"id":2770511,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-03-26T20:45:19.000Z","date":"2021-03-25","kind":"exercise","acquired":true,"shares":394739,"price":3.21,"value":1267112.19,"ownership":{"direct":true},"balance_after":588017,"source":{"system":"sec-edgar","filing":"0001213900-21-018006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021018006/ownership.xml","form_type":"4"}},{"id":2770510,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-03-26T20:45:19.000Z","date":"2021-03-25","kind":"sale","acquired":false,"shares":80000,"price":46.1,"value":3688000.0,"ownership":{"direct":true},"balance_after":193278,"source":{"system":"sec-edgar","filing":"0001213900-21-018006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021018006/ownership.xml","form_type":"4"}},{"id":2770509,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-03-26T20:45:19.000Z","date":"2021-03-24","kind":"sale","acquired":false,"shares":20000,"price":50.5,"value":1010000.0,"ownership":{"direct":true},"balance_after":273278,"source":{"system":"sec-edgar","filing":"0001213900-21-018006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021018006/ownership.xml","form_type":"4"}},{"id":2910876,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2021-01-12T00:04:26.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":28883,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance."}],"balance_after":28883,"derivative":{"exercise_date":"2021-01-07","expiration_date":"2024-01-07","underlying":"Common","underlying_shares":28883},"source":{"system":"sec-edgar","filing":"0001213900-21-001538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021001538/ownership.xml","form_type":"4"}},{"id":2920117,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2021-01-05T21:45:09.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":21186,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":0,"derivative":{"exercise_date":"2020-12-31","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":2920116,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2021-01-05T21:45:09.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":21186,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":21186,"derivative":{"exercise_date":"2020-09-30","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":2920115,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2021-01-05T21:45:09.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":21187,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":63559,"derivative":{"exercise_date":"2020-03-31","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":2920114,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-01-05T21:45:09.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":21186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":293278,"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":2920113,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-01-05T21:45:09.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":21186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":272092,"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":2920112,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-01-05T21:45:09.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":21187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively."}],"balance_after":250906,"source":{"system":"sec-edgar","filing":"0001213900-21-000454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000454/ownership.xml","form_type":"4"}},{"id":3091668,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2020-07-02T20:32:20.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":21187,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187 shares vested as of June 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187 shares vested as of June 30, 2020."}],"balance_after":42372,"derivative":{"exercise_date":"2020-06-30","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001213900-20-016579","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/ownership.xml","form_type":"4"}},{"id":3091667,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2020-07-02T20:32:20.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":21187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187 shares vested as of June 30, 2020."}],"balance_after":229719,"source":{"system":"sec-edgar","filing":"0001213900-20-016579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/ownership.xml","form_type":"4"}},{"id":3098436,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option","published_at":"2020-06-26T12:45:21.000Z","date":"2020-06-24","kind":"exercise","acquired":false,"shares":45261,"price":3.21,"value":145287.81,"ownership":{"direct":true},"balance_after":394739,"derivative":{"exercise_price":3.21,"exercise_date":"2017-02-22","expiration_date":"2021-02-21","underlying":"Common Stock","underlying_shares":45261},"source":{"system":"sec-edgar","filing":"0001213900-20-015899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/ownership.xml","form_type":"4"}},{"id":3098435,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2020-06-26T12:45:21.000Z","date":"2020-06-24","kind":"exercise","acquired":true,"shares":45261,"price":3.21,"value":145287.81,"ownership":{"direct":true},"balance_after":208528,"source":{"system":"sec-edgar","filing":"0001213900-20-015899","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/ownership.xml","form_type":"4"}},{"id":3210949,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Unvested Restricted Stock Award","published_at":"2020-03-13T21:21:36.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":84746,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020."}],"balance_after":84746,"derivative":{"exercise_date":"2020-03-31","expiration_date":"2020-12-31","underlying":"12/31/20","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001213900-20-006361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020006361/ownership.xml","form_type":"4"}},{"id":3224458,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option","published_at":"2020-03-05T18:24:11.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":30000,"price":3.21,"value":96300.0,"ownership":{"direct":true},"balance_after":440000,"derivative":{"exercise_price":3.21,"exercise_date":"2017-02-22","expiration_date":"2021-02-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-20-005495","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/ownership.xml","form_type":"4"}},{"id":3224457,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2020-03-05T18:24:11.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":30000,"price":3.21,"value":96300.0,"ownership":{"direct":true},"balance_after":163267,"source":{"system":"sec-edgar","filing":"0001213900-20-005495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/ownership.xml","form_type":"4"}},{"id":3301558,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-01-27T16:59:50.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":200000,"price":2.25,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option will vest as to one-third of the shares subject to the option on each annual anniversary of January 23, 2020."}],"balance_after":200000,"derivative":{"exercise_price":2.25,"exercise_date":"2021-01-23","expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001019056-20-000027","document":"febbo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905620000027/febbo.xml","form_type":"4"}},{"id":3350800,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option","published_at":"2019-12-05T13:45:45.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":30000,"price":3.21,"value":96300.0,"ownership":{"direct":true},"balance_after":470000,"derivative":{"exercise_price":3.21,"exercise_date":"2017-02-22","expiration_date":"2021-02-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-19-025356","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019025356/ownership.xml","form_type":"4"}},{"id":3350799,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-12-05T13:45:45.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":30000,"price":3.21,"value":96300.0,"ownership":{"direct":true},"balance_after":133267,"source":{"system":"sec-edgar","filing":"0001213900-19-025356","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019025356/ownership.xml","form_type":"4"}},{"id":3378734,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-11-06T21:15:31.000Z","date":"2019-11-06","kind":"purchase","acquired":true,"shares":5000,"price":9.5,"value":47500.0,"ownership":{"direct":true},"balance_after":103267,"source":{"system":"sec-edgar","filing":"0001213900-19-022200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019022200/ownership.xml","form_type":"4"}},{"id":3573975,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Contingent Stock Grant","published_at":"2019-03-29T20:17:09.000Z","date":"2019-03-28","kind":"exercise","acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-19-005239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019005239/ownership.xml","form_type":"4"}},{"id":3573974,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-03-29T20:17:09.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year."}],"balance_after":98267,"source":{"system":"sec-edgar","filing":"0001213900-19-005239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019005239/ownership.xml","form_type":"4"}},{"id":3631973,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Grant","published_at":"2019-02-26T22:19:35.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person received a restricted stock grant that may vest on February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals."}],"balance_after":110000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-19-003164","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019003164/ownership.xml","form_type":"4"}},{"id":3631972,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Option","published_at":"2019-02-26T22:19:35.000Z","date":"2019-02-25","kind":"other","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Issuer and the Reporting Person amended the Reporting Person's employment agreement to vest his options as of February 28, 2019."}],"balance_after":500000,"derivative":{"exercise_price":1.07,"exercise_date":"2019-02-28","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-19-003164","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019003164/ownership.xml","form_type":"4"}},{"id":3723290,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-12-20T13:30:32.000Z","date":"2018-12-19","kind":"purchase","acquired":true,"shares":2000,"price":9.94,"value":19880.0,"ownership":{"direct":true},"balance_after":18267,"source":{"system":"sec-edgar","filing":"0001213900-18-017585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018017585/ownership.xml","form_type":"4"}},{"id":3770523,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-11-08T13:45:34.000Z","date":"2018-11-07","kind":"purchase","acquired":true,"shares":600,"price":16.3197,"value":9791.82,"ownership":{"direct":true},"balance_after":16267,"source":{"system":"sec-edgar","filing":"0001213900-18-015112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018015112/ownership.xml","form_type":"4"}},{"id":3884035,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-06-25T20:23:41.000Z","date":"2018-06-22","kind":"purchase","acquired":true,"shares":1000,"price":10.5,"value":10500.0,"ownership":{"direct":true},"balance_after":15667,"source":{"system":"sec-edgar","filing":"0001213900-18-008163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008163/ownership.xml","form_type":"4"}},{"id":4079100,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Grant","published_at":"2018-02-02T22:16:07.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received a restricted stock grant that may vest on either February 1, 2019 or February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":1740000,"derivative":{"underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001213900-18-001238","document":"f4020118febbo_optimizerx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018001238/f4020118febbo_optimizerx.xml","form_type":"4"}},{"id":4533254,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-12-05T14:15:21.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":4000,"price":0.85,"value":3400.0,"ownership":{"direct":true},"balance_after":44000,"source":{"system":"sec-edgar","filing":"0001213900-16-019141","document":"f4120116febbo_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390016019141/f4120116febbo_optimizerx.xml","form_type":"4"}},{"id":4557779,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-14T14:00:47.000Z","date":"2016-11-10","kind":"purchase","acquired":true,"shares":9000,"price":0.9,"value":8100.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001213900-16-018324","document":"f4111016febbo_optimizerxcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390016018324/f4111016febbo_optimizerxcorp.xml","form_type":"4"}}]}